X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Next-Generation Antibody Therapeutics Companies

This report lists the top Next-Generation Antibody Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Next-Generation Antibody Therapeutics industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Next-Generation Antibody Therapeutics Top Companies

  1. AstraZeneca

  2. Bristol-Myers Squibb

  3. Roche

  4. Pfizer

  5. Seagen

*Disclaimer: Top companies sorted in no particular order

Next-Generation Antibody Therapeutics Market Major Players

Next-Generation Antibody Therapeutics Market Concentration

Next-Generation Antibody Therapeutics  Market Concentration

Next-Generation Antibody Therapeutics Company List

                            • Amgen Inc.

                            • AstraZeneca Plc.

                            • Bayer AG

                            • Biogen

                            • Bristol-Myers Squibb Company

                            • GlaxoSmithKline Plc.

                            • F. Hoffmann-La Roche Ltd

                            • ImmunoGen Inc.

                            • Kyowa Hakko Kirin Co., Ltd.

                            • Pfizer Inc.

                            • Seagen Inc.

                            • Xencor, Inc.


                        Specific to Next-Generation Antibody Therapeutics Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Next-Generation Antibody Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)